SEI Investments’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-20,956
Closed -$586K 2501
2019
Q3
$586K Buy
+20,956
New +$340K ﹤0.01% 1811
2018
Q2
Sell
-89
Closed -$2K 3909
2018
Q1
$2K Hold
89
﹤0.01% 3291
2017
Q4
$3K Buy
+89
New +$2.44K ﹤0.01% 3085

SEI Investments's DOVA Position: Q4 2019 in Review

SEI Investments sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 20,956 shares — an estimated $586K sold.

SEI Investments first reported a position in DOVA in Q4 2017 and held it in 3 quarters. The position peaked at $586K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • SEI Investments reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • SEI Investments sold 20,956 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $586K.
  • SEI Investments first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • SEI Investments's Dova Pharmaceuticals, Inc. Common Stock position peaked at $586K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on SEI Investments's 13F filing for Q4 2019, filed 6 Feb 2020.